v-myb and v-ets transform chicken erythroid cells and cooperate both in trans and in cis to induce distinct differentiation phenotypes
- PMID: 2001839
- DOI: 10.1101/gad.5.3.369
v-myb and v-ets transform chicken erythroid cells and cooperate both in trans and in cis to induce distinct differentiation phenotypes
Abstract
E26 is an acute avian leukemia virus that encodes the transcriptional activator oncogenes v-myb and v-ets in a single fusion protein. This virus is also unique in that it is able to transform hematopoietic cells of both the myeloid and the erythroid lineage. To determine the contributions of v-myb and v-ets to the transforming potential of the virus, derivatives expressing separate Myb and Ets proteins, either alone or in combination, were constructed. We found that in the myeloid lineage v-myb, but not v-ets, induces cell transformation. In the erythroid lineage both v-myb and v-ets weakly transform erythroblast-like cells. These cells exhibit a mature phenotype and a low self-renewal capacity. The transforming efficiency of the two oncogenes is enhanced if they are coexpressed as separate proteins or as a fusion protein, the transformed cells displaying an increased self-renewal capacity. Interestingly, however, cells transformed by the Myb-Ets fusion protein have a distinct phenotype in that they are very immature. These results demonstrate that v-myb and v-ets can cooperate in the transformation of erythroid cells both in trans and in cis and that the mode of cooperation is reflected by the differentiation phenotypes of the transformed cells.
Similar articles
-
The various domains of v-myb and v-ets oncogenes of E26 retrovirus contribute differently, but cooperatively, in transformation of hematopoietic lineages.Oncogene. 1992 Nov;7(11):2231-41. Oncogene. 1992. PMID: 1331935
-
Fusion of the nuclear oncoproteins v-Myb and v-Ets is required for the leukemogenicity of E26 virus.Cell. 1991 Jul 12;66(1):95-105. doi: 10.1016/0092-8674(91)90142-l. Cell. 1991. PMID: 2070421
-
A single point mutation in the v-ets oncogene affects both erythroid and myelomonocytic cell differentiation.Cell. 1988 Dec 23;55(6):1147-58. doi: 10.1016/0092-8674(88)90259-0. Cell. 1988. PMID: 3203383
-
Molecular analysis of the ets genes and their products.Crit Rev Oncog. 1990;1(4):409-36. Crit Rev Oncog. 1990. PMID: 1964597 Review.
-
Transformation by v-Myb.Oncogene. 1999 May 13;18(19):3047-55. doi: 10.1038/sj.onc.1202745. Oncogene. 1999. PMID: 10378700 Review.
Cited by
-
A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein.EMBO J. 1997 Jan 2;16(1):69-82. doi: 10.1093/emboj/16.1.69. EMBO J. 1997. PMID: 9009269 Free PMC article.
-
Transactivation of erythroid transcription factor GATA-1 by a myb-ets-containing retrovirus.J Virol. 1992 May;66(5):3056-61. doi: 10.1128/JVI.66.5.3056-3061.1992. J Virol. 1992. PMID: 1560536 Free PMC article.
-
Myb proteins: angels and demons in normal and transformed cells.Front Biosci (Landmark Ed). 2011 Jan 1;16(3):1109-31. doi: 10.2741/3738. Front Biosci (Landmark Ed). 2011. PMID: 21196221 Free PMC article. Review.
-
A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.Nucleic Acids Res. 1994 Sep 25;22(19):3871-9. doi: 10.1093/nar/22.19.3871. Nucleic Acids Res. 1994. PMID: 7937106 Free PMC article.
-
A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions.Mol Cell Biol. 1998 Apr;18(4):2218-29. doi: 10.1128/MCB.18.4.2218. Mol Cell Biol. 1998. PMID: 9528793 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources